People with Type 1 Diabetes Have a Smart Stop Online with JDRF’s New Issue of Countdown
July 11, 2011
Media Contact: Joana Casas, 212.479.7560, firstname.lastname@example.org
–Online magazine features news on research progress in the prevention of type 1 diabetes, an in-depth story on diabetes vaccines, a user-friendly roadmap for personal health information, and a stress-free guide to traveling with type 1 diabetes–
NEW YORK, N.Y., July 11, 2011-The Juvenile Diabetes Research Foundation (JDRF) last week released its new issue of Countdown, the organization’s magazine-now online-which features important news about type 1 diabetes. The issue brings readers information about the most current advances in research as well as helpful strategies for living with the disease.
The June 2011 issue of Countdown includes:
Vaccines: Tackling the Root Causes of Type 1 Diabetes: This second installment of a two-part series on type 1 diabetes vaccines shares how new insights into the immune system, and into its relationship with beta cells, are helping scientists discover and develop diabetes vaccines. Detailing some of the avenues that scientists are exploring and why, and how JDRF is involved, the article brings much-needed light to a very complex subject.
Preventing Type 1 Diabetes: While there is no known cause of type 1 diabetes, research has illuminated a number of possible factors that could contribute to the disease, from genetics to the environment. As JDRF remains committed to curing type 1 diabetes, it also aims to improve the lives and health of people with the disease through better treatments, and to prevent the disease in people at risk. Authored by JDRF’s chief scientific officer, Richard Insel, M.D., this piece details some of the findings in diabetes research that have led scientists to understand the importance of digging deeper into possible preventative measures for type 1 diabetes. Dr. Insel explains about some of the clinical trials underway, and what this research means for people with and at risk for type 1 diabetes.
Research Highlights: This section is a window into the latest in type 1 diabetes research-from a new therapy for diabetic eye disease to updates on clinical trials for preventing type 1 diabetes.
Know Your Numbers: This article walks the reader through a comprehensive guide to health “numbers.” Balancing blood pressure, weight, and cholesterol is challenging enough in itself, and it is especially important for people with type 1 diabetes. Though these numbers can seem daunting to those with the disease, once they’re understood, they can play a key role in maintaining good health. In addition to explaining healthy blood glucose numbers, the story delves into healthy cholesterol numbers; discusses ideal weights according to age and height; and gives a breakdown of how these measurements affect-and are affected by-type 1 diabetes. The story also features an interactive quiz to test the reader’s knowledge of type 1 diabetes numbers.
Traveling with Diabetes: Just in time for the summer travel season, this article tackles a topic that can raise a multitude of thorny questions for people with type 1 diabetes and their families. From concerns over safely transporting supplies to worries about what to do in an emergency while away from home, the story arms families with a sense of clarity and preparedness, including measures to take before traveling, while traveling, and at the destination. It also includes a Travel Checklist for people with diabetes to use.
To read this current issue of Countdown, and browse past features, visit http://countdown.jdrf.org/.
JDRF is the worldwide leader for research to cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide.
The mission of JDRF is to find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump – each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation.
Since its founding in 1970 by parents of children with type 1 diabetes, JDRF has awarded more than $1.5 billion to diabetes research, including $107 million last year. More than 80 percent of JDRF’s expenditures directly support research and research-related education. For more information, please visit www.jdrf.org.
JDRF is the leading global organization focused on type 1 diabetes (T1D) research. Driven by passionate, grassroots volunteers connected to children, adolescents, and adults with this disease, JDRF is now the largest charitable supporter of T1D research. The goal of JDRF research is to improve the lives of all people affected by T1D by accelerating progress on the most promising opportunities for curing, better treating, and preventing T1D. JDRF collaborates with a wide spectrum of partners who share this goal.
Since its founding in 1970, JDRF has awarded more than $1.7 billion to diabetes research. Past JDRF efforts have helped to significantly advance the care of people with this disease, and have expanded the critical scientific understanding of T1D. JDRF will not rest until T1D is fully conquered. More than 80 percent of JDRF’s expenditures directly support research and research-related education.